Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/24 → 30/11/24 |
Funding
- Wellcome Trust (Rcl): £20,000.00
Validating a Screen for Compounds Which Reverse Suppressive Tumour‐Associated Macrophage Phenotype or Boost NK Cell Function to Improve Cancer Treatment
- Doughty Shenton, Dahlia (Principal Investigator)
- Kitamura, Takanori (Co-investigator)